Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm

BackgroundLiterature derived knowledge assemblies have been used as an effective way of representing biological phenomenon and understanding disease etiology in systems biology. These include canonical pathway databases such as KEGG, Reactome and WikiPathways and disease specific network inventories such as causal biological networks database, PD map and NeuroMMSig. The represented knowledge in these resources delineates qualitative information focusing mainly on the causal relationships between biological entities. Genes, the major constituents of knowledge representations, tend to express differentially in different conditions such as cell types, brain regions and disease stages. A classical approach of interpreting a knowledge assembly is to explore gene expression patterns of the individual genes. However, an approach that enables quantification of the overall impact of differentially expressed genes in the corresponding network is still lacking.ResultsUsing the concept of heat diffusion, we have devised an algorithm that is able to calculate the magnitude of regulation of a biological network using expression datasets. We have demonstrated that molecular mechanisms specific to Alzheimer (AD) and Parkinson Disease (PD) regulate with different intensities across spatial and temporal resolutions. Our approach depicts that the mitochondrial dysfunction in PD is severe in cortex and advanced stages of PD patients. Similarly, we have shown that the intensity of aggregation of neurofibrillary tangles (NFTs) in AD increases as the disease progresses. This finding is in concordance with previous studies that explain the burden of NFTs in stages of AD.ConclusionsThis study is one of the first attempts that enable quantification of mechanisms represented as biological networks. We have been able to quantify the magnitude of regulation of a biological network and illustrate that the magnitudes are different across spatial and temporal resolution.

[1]  Jie Shen,et al.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.

[2]  Sangyun Jeong,et al.  Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease , 2017, Molecules and cells.

[3]  D. Galasko,et al.  Distinctive patterns of DNA methylation associated with Parkinson disease , 2013, Epigenetics.

[4]  V. Bader,et al.  Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. , 2007, Human molecular genetics.

[5]  Martin Hofmann-Apitius,et al.  Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs , 2017, Journal of Alzheimer's disease : JAD.

[6]  A. Bauer-Mehren,et al.  Pathway databases and tools for their exploitation: benefits, current limitations and challenges , 2009, Molecular systems biology.

[7]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[8]  Isidre Ferrer,et al.  Early involvement of the cerebral cortex in Parkinson's disease: Convergence of multiple metabolic defects , 2009, Progress in Neurobiology.

[9]  Manuel C. Peitsch,et al.  Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks , 2012, BMC Systems Biology.

[10]  Sunjoo Jeong,et al.  SR Proteins: Binders, Regulators, and Connectors of RNA , 2017, Molecules and cells.

[11]  Kun-Liang Guan,et al.  Dysregulation of the TSC-mTOR pathway in human disease , 2004, Nature Genetics.

[12]  Lincoln D. Stein,et al.  Impact of outdated gene annotations on pathway enrichment analysis , 2016, Nature Methods.

[13]  Martin Hofmann-Apitius,et al.  Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis , 2015, Alzheimer's & Dementia.

[14]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[15]  Charles Auffray,et al.  Navigating the disease landscape: knowledge representations for contextualizing molecular signatures , 2018, Briefings Bioinform..

[16]  Kei-Hoi Cheung,et al.  BioPAX – A community standard for pathway data sharing , 2010, Nature Biotechnology.

[17]  Ricardo Nitrini,et al.  Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans , 2018, Neurobiology of Aging.

[18]  Nahum Sonenberg,et al.  The Akt of translational control , 2005, Oncogene.

[19]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[20]  Natalie L. Catlett,et al.  Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data , 2013, BMC Bioinformatics.

[21]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[22]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[23]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[24]  A Smith,et al.  Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus , 2015, Molecular Psychiatry.

[25]  Ana Navarro,et al.  Brain Mitochondrial Dysfunction in Aging, Neurodegeneration, and Parkinson's Disease , 2010, Front. Ag. Neurosci..

[26]  Ryan Miller,et al.  WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research , 2017, Nucleic Acids Res..

[27]  Veerle Baekelandt,et al.  Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism , 2014, Front. Genet..

[28]  Mohammad Asif Emon,et al.  Multimodal mechanistic signatures for neurodegenerative diseases (NeuroMMSig): a web server for mechanism enrichment , 2017, Bioinform..

[29]  Masato Kasuga,et al.  [Mechanism of insulin action and diabetes mellitus]. , 2003, Seikagaku. The Journal of Japanese Biochemical Society.

[30]  Michal Sheffer,et al.  Pathway-based personalized analysis of cancer , 2013, Proceedings of the National Academy of Sciences.

[31]  Chris J. Myers,et al.  The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 2 Core Release 2 , 2018, J. Integr. Bioinform..

[32]  Junhee Seok,et al.  Mice are not men , 2014, Proceedings of the National Academy of Sciences.

[33]  Chris J. Myers,et al.  The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 2 Core , 2018, J. Integr. Bioinform..